Beacon Harbor Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-71,459
Closed -$6.19M 81
2026
Q1
$6.19M Buy
71,459
+2,508
+4% +$240K 1.3% 41
2025
Q4
$6.62M Buy
+68,951
New +$6.7M 1.47% 30
2025
Q1
Sell
-32,001
Closed -$2.56M 88
2024
Q4
$2.56M Sell
32,001
-41,046
-56% -$3.55M 0.6% 48
2024
Q3
$6.58M Buy
73,047
+1,587
+2% +$134K 1.56% 31
2024
Q2
$5.63M Buy
71,460
+3,728
+6% +$306K 1.46% 37
2024
Q1
$5.9M Buy
67,732
+669
+1% +$57.1K 1.56% 31
2023
Q4
$5.53M Buy
67,063
+2,287
+4% +$174K 1.61% 29
2023
Q3
$5.08M Buy
64,776
+1,253
+2% +$105K 1.69% 23
2023
Q2
$5.6M Sell
63,523
-1,445
-2% -$124K 1.83% 16
2023
Q1
$5.24M Buy
64,968
+7,524
+13% +$613K 1.83% 25
2022
Q4
$4.46M Buy
+57,444
New +$4.66M 1.52% 30

Other funds holding MDT

Beacon Harbor Wealth Advisors's MDT Position: Q2 2026 in Review

Beacon Harbor Wealth Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 71,459 shares — an estimated $6.19M sold.

Beacon Harbor Wealth Advisors first reported a position in MDT in Q4 2022 and held it in 11 quarters. The position peaked at $6.62M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Beacon Harbor Wealth Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Beacon Harbor Wealth Advisors sold 71,459 Medtronic shares in Q2 2026, an estimated $6.19M.
  • Beacon Harbor Wealth Advisors first reported a position in Medtronic in Q4 2022 and held it in 11 quarters.
  • Beacon Harbor Wealth Advisors's Medtronic position peaked at $6.62M in Q4 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Beacon Harbor Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.